Wednesday, April 27, 2016 7:26:03 PM
All well and good to observe "... current 2016 armor plates are both lighter weight and more efficient to withstand more impacts."
Yes, but the same concern expressed as an issue in 2011 may still be present for these 2016 plates such that until resolved there is no possibility for a substantial revenue stream for Bourque Industries selling armor plates.
This issue was identified by person Sean Floyd that held positions of Sr. Vice-President to the CEO of Bourque Industries, and Interim CEO of Bourque Industries, that being "... the cost to produce for commercial applications is prohibited."
Once again, if true then only samples can be manufactured by Bourque Industries for demonstrations, that with a possible less than a dozen private sales to law enforcement at a purchase cost far less than that required by Bourque Industries to manufacture.
So once again, as in 2011, all accounts of Kryron's 2016 armor service superior performance resides in the same context as all such potentials for Kryron mentioned on the company web site, with emphasis here directed towards the wire initiative that may at this point in development have a manufacturing cost to produce being prohibited for marketplace sales.
All this may simply mean that there are no current possible sales of Kryron applications, and when manufacturing cost can be adjusted sufficiently downwards is unknown at this time, meaning... tune in this time in 2017 for a possible update by Bourque Industries.
The posts contained on my (gotmilk) account are my own opinions and are not recommendations or advise to buy or sell any security, stocks or other investments. These posts are for entertainment purposes only and are not considered to be facts or truth.
The posts contained on my (gotmilk) account are my own opinions and are not recommendations or advise to buy or sell any security, stocks or other investments. These posts are for entertainment purposes only and are not considered to be facts or truth.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM